Prosecution Insights
Last updated: May 29, 2026

Florek & Endres Pllc

13 pending office actions • 12 clients • 13 examiners • 13 art units • 0 of 13 (0%) have an AI response strategy ready • 44 patents granted in the last 365 days

Portfolio Summary

13
Total Pending OAs
2
Non-Final OAs
10
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 13 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

7
Overdue
0
Due this week
2
Due this month
1
Due in next 60 days
3
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 13 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (7)Due ≤ 30 days (2)Due ≤ 60 days (1)Due later (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
9
Medium (69%)
1
Easy (8%)
3
Unknown (23%)

Rejection Statute Mix

BucketCases
§103 only8 (62%)
§102 only1 (8%)
§112 only1 (8%)
No statute on record3 (23%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
46% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
2
Semiconductors
15% of docket
4
Mechanical / Eng
31% of docket
1
Business / Other
8% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

130 h
Manual time on pending OAs
26 h
Time saved (low, 20%)
46 h
Time saved (mid, 35%)
1.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
TRAN, ERIC 1 68.7% +24.7%
WOOD, SAMANTHA N 1 92.0% -3.4%
SHI, KATHERINE MENGLIN 1 78.5% +22.0%
LAPAGE, MICHAEL P 1 78.8% +34.2%
KEENA, ELLA LORRAINE 1 22.2% +87.5%
SMITH, PETER DANIEL 1 49.2% +50.0%
ZHENG, LI 1 83.7% +13.3%
KIM, DANIELLE A 1 37.2% +58.0%
TOMBERS, JOSEPH A 1 46.2% +31.1%
JACKSON, JORDAN L 1 40.8% +38.5%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
35522683 Faucet WOOD, SAMANTHA N 20d
18279470 GENETIC STABILIZER AND GROWTH SELECTOR FOR GENETIC TRANSFORMATION OF THE CHLOROPLAST GENOME OF MICROALGAE ZHENG, LI 62d

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18429075 DERMAPLANE RAZOR KEENA, ELLA LORRAINE 57d

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18931783 KINASE INHIBITOR SALTS AND COMPOSITIONS THEREOF TRAN, ERIC 155d overdue
18025092 METHOD FOR THE MANAGEMENT OF ORAL THERAPY IN PARKINSON'S DISEASE JACKSON, JORDAN L 155d overdue
18570437 ADAPTER FOR CLINICAL, MEDICAL AND LABORATORY CONTAINERS SMITH, PETER DANIEL 31d overdue
18710778 MULTIPLEX CARS MICROSCOPY DEVICE LAPAGE, MICHAEL P 5d overdue
18025069 METHOD AND DEVICE FOR THE OBJECTIVE CHARACTERIZATION OF SYMPTOMS OF PARKINSON'S DISEASE TOMBERS, JOSEPH A 2d overdue
18790134 MICRODERMABRASION SYSTEM WITH ERGONOMIC HANDLE SHI, KATHERINE MENGLIN 15d
18429075 DERMAPLANE RAZOR KEENA, ELLA LORRAINE 57d
18279470 GENETIC STABILIZER AND GROWTH SELECTOR FOR GENETIC TRANSFORMATION OF THE CHLOROPLAST GENOME OF MICROALGAE ZHENG, LI 62d

Client Portfolio (12 clients)

Top Art Units

Art UnitApps
16291
29141
37711
28771
37241
37811
16621
16131
37911
28571

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18931783 KINASE INHIBITOR SALTS AND COMPOSITIONS THEREOF Handa Oncology, LLC TRAN, ERIC 1629 Other Non-Final OA 155d overdue Pending Oct 30, 2024
35522683 Faucet Duravit Aktiengesellschaft WOOD, SAMANTHA N 2914 §112 Final Rejection 20d Pending Oct 02, 2024
18790134 MICRODERMABRASION SYSTEM WITH ERGONOMIC HANDLE Envy Medical, Inc. SHI, KATHERINE MENGLIN 3771 Other Non-Final OA 15d Pending Jul 31, 2024
18710778 MULTIPLEX CARS MICROSCOPY DEVICE Centre National De La Recherche Scientifique LAPAGE, MICHAEL P 2877 §103 Final Rejection 5d overdue Pending May 16, 2024
18429075 DERMAPLANE RAZOR Harry'S, Inc. KEENA, ELLA LORRAINE 3724 §103 Final Rejection 57d Pending Jan 31, 2024
18570437 ADAPTER FOR CLINICAL, MEDICAL AND LABORATORY CONTAINERS Vertice Pharma LLC SMITH, PETER DANIEL 3781 §103 Non-Final OA 31d overdue Pending Dec 14, 2023
18279470 GENETIC STABILIZER AND GROWTH SELECTOR FOR GENETIC TRANSFORMATION OF THE CHLOROPLAST GENOME OF MICROALGAE Luca Dall'Osto ZHENG, LI 1662 §103 Final Rejection 62d Pending Aug 30, 2023
18278082 SILK FIBROIN BIOINKS AND RELATED USE FOR 3D BIOPRINTING Cellink KIM, DANIELLE A 1613 §103 Final Rejection 63d Pending Aug 21, 2023
18025069 METHOD AND DEVICE FOR THE OBJECTIVE CHARACTERIZATION OF SYMPTOMS OF PARKINSON'S DISEASE Brain Innovations, S.r.l. TOMBERS, JOSEPH A 3791 §102 Final Rejection 2d overdue Pending Mar 07, 2023
18025092 METHOD FOR THE MANAGEMENT OF ORAL THERAPY IN PARKINSON'S DISEASE Brain Innovations, S.r.l. JACKSON, JORDAN L 2857 Other Final Rejection 155d overdue Pending Mar 07, 2023
18022159 COLLOIDAL SOLUTION FOR EX-VIVO LUNG PERFUSION AND STORAGE S.A.L.F. S.p.A. Laboratorio Farmacologico VAN BUREN, LAUREN K 1638 §103 Final Rejection 82d Pending Feb 19, 2023
17802588 FORMULATION BASED ON POLYHEXAMETHYLENE BIGUANIDE FOR USE IN THE TREATMENT OF ACANTHAMOEBA KERATITIS AND/OR FUNGAL INFECTIONS Sifi S.p.A. FAY, ZOHREH ALEMZADEH 1617 §103 Final Rejection 24d overdue Pending Aug 26, 2022
16965974 EXTRACELLULAR VESICLES DERIVED FROM CELLS CULTURED UNDER HYPOXIC CONDITIONS AND USES THEREOF Allergan Sales, LLC BOECKELMAN, JACOB A 1655 §103 Final Rejection 8d overdue Pending Jul 29, 2020

Managing Florek & Endres Pllc's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month